中国血液净化

中国血液净化 ›› 2023, Vol. 22 ›› Issue (06): 467-471.doi: 10.3969/j.issn.1671-4091.2023.06.015

• 护理研究 • 上一篇    下一篇

风险分级管理对慢性肾脏病高钾血症患者的效果研究

刘芳芳   娄小平   王文娇   张彤彤   郑 晓   陈 婕   李争艳   

  1. 450052 郑州，郑州大学第一附属医院1肾内二科 2护理部
  • 收稿日期:2022-12-14 修回日期:2023-03-07 出版日期:2023-06-12 发布日期:2023-06-12
  • 通讯作者: 娄小平 E-mail:Lou Xiaoping@163.com
  • 基金资助:
    中华护理学会科研项目(ZHKY202112)

Clinical practice of grading management scheme for hyperkalemia in chronic kidney disease patients

LIU Fang-fang, LOU Xiao-ping, WANG Wen-jiao, ZHANG Tong-tong, ZHENG Xiao, CHEN Jie, LI Zheng-yan   

  1. The Second Department of Nephrology and 2Nuring Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
  • Received:2022-12-14 Revised:2023-03-07 Online:2023-06-12 Published:2023-06-12
  • Contact: 450052 郑州，郑州大学第一附属医院 2护理部 E-mail:Lou Xiaoping@163.com

PDF

199

摘要： 目的 探究风险分级管理对慢性肾脏病高钾血症患者的影响。方法 选取郑州大学第一附属医院90例慢性肾脏病患者作为研究对象，采用随机抽样法将其分为对照组和试验组，各45例。对照组实施常规护理，试验组在常规护理的基础上实施风险分级管理方案，比较2组干预前后高钾血症发生率、高钾血症认知水平、服药依从性及饮食依从性。 结果 试验组高钾血症发生率低于对照组(χ2=4.444，P=0.035)，试验组高钾血症认知(t=-7.071，P＜0.001)、服药依从性(t=-3.081，P=0.004)及饮食依从性 (t=-8.785，P＜0.001)高于对照组。 结论 对慢性肾脏病患者应用风险分级管理方案，可降低患者高钾血症发生率，提高高钾认知水平，促进患者养成良好的服药及饮食依从行为，有利于降低不良事件的发生。

关键词: 慢性肾脏病, 高钾血症, 风险分级管理, 依从性

Abstract: Objective   This paper is to explore the effects of risk grading management scheme on chronic renal disease patients with hyperkalemia.  Method  A total of 90 patients with chronic kidney disease in the First Affiliated Hospital of Zhengzhou University were selected as the research objects. They were randomly divided into control group and experimental group and 45 cases in each group. The control group was given routine nursing care, while the experimental group was used the risk grading management program in addition to routine nursing care. The incidence and the cognitive level of hyperkalemia, the medication compliance and diet compliance for hyperkalemia were compared before and after intervention between the two groups.  Results   The incidence of hyperkalemia was significantly lower in experimental group than in control group (c2=4.444,P=0.035); the cognition of hyperkalemia risks (t=-7.071, P<0.001), the medication compliance (t=          -3.081, P=0.004) and the diet compliance (t=-8.785, P<0.001) were also higher in experimental group than in control group.  Conclusion   The application of risk grading management scheme on patients can reduce the incidence of hyperkalemia, improve the cognitive level and help patients develop good behaviors of medication and diet compliance, to reduce the occurrence of adverse events.

Key words: Chronic kidney disease, Hyperkalemia, Risk grading management, Compliance

中图分类号: